The price of XRP surged on September 22, despite the broader cryptocurrency market experiencing a heavy downturn.
In particular, the XRP token has climbed into double-figure gains, trading at $0.4453, up 10.48% on the day and a further 33% in the last week, according to data retrieved by Finbold from CoinMarketCap.

Currently, the total market cap of XRP stands at $22.17 billion after the digital asset added over $2 billion to its total worth in the last day, climbing from $20.1 billion.

It’s worth noting Finbold noted in its report on September 21 the bullish bias may see XRP break resitance at $0.4215 in its technical analysis:
“The token’s price has rebounded from the last drop and is currently trading with a bullish bias. The bulls are seeking to break through the resistance around $0.4215, and if they are successful, XRP may potentially aim for highs of $0.48 in the near future.”





All while Pfizer—a company with a $2.3 billion criminal fine for fraudulent marketing, bribery, and kickbacks—was given blanket immunity from liability and billions in taxpayer dollars to produce a vaccine in record time with no long-term safety data.










